EA200300247A1 - Фармацевтическая композиция, содержащая циталопрам - Google Patents

Фармацевтическая композиция, содержащая циталопрам

Info

Publication number
EA200300247A1
EA200300247A1 EA200300247A EA200300247A EA200300247A1 EA 200300247 A1 EA200300247 A1 EA 200300247A1 EA 200300247 A EA200300247 A EA 200300247A EA 200300247 A EA200300247 A EA 200300247A EA 200300247 A1 EA200300247 A1 EA 200300247A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutically acceptable
cytalopra
pharmaceutical composition
citalopram
composition containing
Prior art date
Application number
EA200300247A
Other languages
English (en)
Russian (ru)
Inventor
Кен Лильегрен
Пер Хольм
Оле Нильсен
Свен Вагнер
Original Assignee
Х.Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200300247(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х.Лундбекк А/С filed Critical Х.Лундбекк А/С
Publication of EA200300247A1 publication Critical patent/EA200300247A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200300247A 2000-08-10 2001-07-30 Фармацевтическая композиция, содержащая циталопрам EA200300247A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
PCT/DK2001/000520 WO2001080619A2 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram

Publications (1)

Publication Number Publication Date
EA200300247A1 true EA200300247A1 (ru) 2003-06-26

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300247A EA200300247A1 (ru) 2000-08-10 2001-07-30 Фармацевтическая композиция, содержащая циталопрам

Country Status (34)

Country Link
EP (1) EP1318805A2 (cs)
JP (1) JP2003531153A (cs)
KR (1) KR20030024833A (cs)
CN (1) CN1446089A (cs)
AR (1) AR030095A1 (cs)
AT (1) AT5744U1 (cs)
AU (2) AU2001100198B4 (cs)
BE (1) BE1013559A6 (cs)
BG (1) BG107578A (cs)
BR (1) BR0113250A (cs)
CA (1) CA2353693C (cs)
CH (2) CH694242A5 (cs)
CZ (1) CZ2003397A3 (cs)
DE (2) DE10139115A1 (cs)
EA (1) EA200300247A1 (cs)
ES (1) ES2172481B2 (cs)
FI (1) FI5176U1 (cs)
FR (1) FR2812811B1 (cs)
GB (1) GB2368014B (cs)
GR (1) GR1004193B (cs)
HR (1) HRP20030054A2 (cs)
HU (1) HUP0103071A3 (cs)
IE (1) IES20010693A2 (cs)
IL (1) IL154050A0 (cs)
IS (1) IS6021A (cs)
IT (1) ITMI20011637A1 (cs)
MX (1) MXPA03000837A (cs)
NL (1) NL1018741C1 (cs)
NO (1) NO20013891L (cs)
NZ (1) NZ523785A (cs)
PL (1) PL359824A1 (cs)
SK (1) SK2842003A3 (cs)
WO (1) WO2001080619A2 (cs)
YU (1) YU9003A (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
DK1578738T3 (da) * 2002-12-23 2008-06-30 Lundbeck & Co As H Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106397249A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种高稳定性lcz696结晶粉末及其制备方法
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form
WO2024165628A1 (en) 2023-02-07 2024-08-15 Kinast Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
WO2001080619A3 (en) 2002-02-21
NL1018741C1 (nl) 2002-02-12
HUP0103071A3 (en) 2002-12-28
JP2003531153A (ja) 2003-10-21
AU2001100198A4 (en) 2001-08-16
IL154050A0 (en) 2003-07-31
WO2001080619A2 (en) 2001-11-01
BR0113250A (pt) 2003-06-24
NO20013891D0 (no) 2001-08-09
YU9003A (sh) 2006-05-25
NZ523785A (en) 2004-09-24
DE20113195U1 (de) 2001-11-15
FR2812811A1 (fr) 2002-02-15
AU2001100198B4 (en) 2002-06-13
CN1446089A (zh) 2003-10-01
CH694241A5 (de) 2004-10-15
BE1013559A6 (fr) 2002-03-05
MXPA03000837A (es) 2003-06-06
FR2812811B1 (fr) 2006-08-18
CA2353693C (en) 2003-07-22
EP1318805A2 (en) 2003-06-18
ES2172481B2 (es) 2004-08-01
HU0103071D0 (en) 2001-10-28
GR20010100377A (el) 2002-09-06
ES2172481A1 (es) 2002-09-16
GR1004193B (el) 2003-03-24
BG107578A (bg) 2003-09-30
PL359824A1 (en) 2004-09-06
CH694242A5 (de) 2004-10-15
DE10139115A1 (de) 2002-03-28
HUP0103071A2 (hu) 2002-05-29
FI5176U1 (fi) 2001-12-27
KR20030024833A (ko) 2003-03-26
AT5744U1 (de) 2002-11-25
CA2353693A1 (en) 2002-01-22
NO20013891L (no) 2002-02-11
IES20010693A2 (en) 2002-07-10
GB2368014A (en) 2002-04-24
AU2001279591A1 (en) 2001-11-07
ITMI20011637A1 (it) 2003-01-27
GB2368014B (en) 2004-06-23
AR030095A1 (es) 2003-08-13
ITMI20011637A0 (it) 2001-07-27
IS6021A (is) 2001-10-20
SK2842003A3 (en) 2003-09-11
CZ2003397A3 (cs) 2003-06-18
HRP20030054A2 (en) 2005-02-28
GB0118579D0 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
EA200300247A1 (ru) Фармацевтическая композиция, содержащая циталопрам
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
EA200301223A1 (ru) Лекарственные формы окскарбазепина
EA200400862A1 (ru) Твёрдая лекарственная форма, содержащая сердцевинную таблетку с активным фармацевтическим ингредиентом, покрытую кольцеобразной оболочкой из спрессованного порошкообразного или гранулированного материала, способ приготовления такой лекарственной формы и устройство для её приготовления
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
EA199900026A1 (ru) Быстрорастворимая таблетка гидробромида галантамина
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
EA200300104A1 (ru) НОВАЯ γ КРИСТАЛЛИЧЕСКАЯ ФОРМА ТРЕТ-БУТИЛАМИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЕЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
EA199900709A1 (ru) Таблетка для глотания, включающая в себя парацетамол
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
ES8700935A1 (es) Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada
KR850001693A (ko) 아모술랄롤 하이드로클로라이드 지속성 제제의 제조방법
EA200000487A1 (ru) Композиция пролонгированного высвобождения
EA200300597A1 (ru) Бифенилкарбоксамиды, полезные в качестве снижающих содержание липидов агентов
SE8901003D0 (sv) Snabbloesliga preparat
ES551436A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
EA200201003A1 (ru) Аморфная модификация торасемида
EA200300768A1 (ru) Фармацевтическая композиция, содержащая циталопрам
EA200101106A1 (ru) Фармацевтический комплекс
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist